Feasibility of a Mechanical Power-Guided Lung Protective Ventilation (VentCoach) in Acute Hypoxemic and/or Hypercapnic Respiratory Failure

Overview

Información sobre este estudio

The purpose of this study is to assess the feasibility of implementation of, and adherence to VentCoach protocol in critically ill patients intubated for acute hypoxemic and/or hypercapnic respiratory failure. We hypothesize that, when compared to standard of care, VentCoach is feasible, safe, and easy to implement]

 

Elegibilidad para la participación

Los requisitos de elegibilidad de los participantes incluyen la edad, el sexo, el tipo y el estadio de la enfermedad, y los problemas de salud o tratamientos previos. Las pautas difieren de un estudio a otro e identifican quiénes pueden o no pueden participar. No hay garantía de que cada persona elegible que desee participar en un ensayo se inscribirá. Comunícate con el equipo del estudio para analizar la elegibilidad del estudio y la posible participación.

Inclusion Criteria:

  • Patients with acute hypoxemic and/or hypercapnic respiratory failure.
  • Patients requiring intubation and mechanical ventilation for more than 24 hours.
  • VentCoach protocol is specific to volume controlled continuous mandatory ventilation (S-CMV).
  • Patient who are admitted to RMH 10-3/10-4 and MB 6BGF ICUs.
  • Age greater than or equal to 18 years.
  • Patient’s legal representative should be able to provide informed consent to the study. Any participant speaking any language will be offered participation.

Exclusion Criteria:

  • Intubation and mechanical ventilation for airway protection in the setting of procedures/surgeries; e.g. interventional radiology, surgery, or endoscopy.
  • Intubation and mechanical ventilation due to drug overdose with expected extubation of less than 24 hours.
  • Intubation and mechanical ventilation in the setting of cardiac arrest of primary cardiac etiology.
  • Intubation and mechanical ventilation for a primary neurological etiology; e.g. increased intracranial pressure, tumor mass effect, ischemic/hemorrhagic stroke, status epilepticus, etc.
  • Mechanical ventilation to be guided by esophageal balloon.
  • Subject deprived of freedom, minor, subject under a legal protective measure.
  • Change in end-of-life decision anticipated after enrollment (or estimated 6-month mortality rate of greater than 50%).

Note: Prone positioning is not a contraindication for participation.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 5/22/23. Questions regarding updates should be directed to the study team contact.

 

Sedes participantes de Mayo Clinic

Los estatus de los estudios cambian con frecuencia. Comunícate con el equipo del estudio para obtener la información más actualizada acerca de la posibilidad de participar.

Sede de Mayo Clinic Estatus Contacto

Rochester, Minn.

Investigador principal de Mayo Clinic

Gustavo Cortes Puentes, M.D.

Abierto para la inscripción

Contact information:

Brandon Clapp

(507) 284-2122

Clapp.Brandon@mayo.edu

More information

Publicaciones

Publications are currently not available
.
CLS-20555865

Mayo Clinic Footer